The more inaccurate a diagnosis, the less chance the patient can receive the appropriate treatment. This impacts not only the patient’s health, but the sustainability of the system as a whole.
With the aim of finding personalized and innovative solutions, the Roche 2019 Challenge, in partnership with Innoscience and StartSe, invites startups to seek innovative personalized medicine solutions, offering startups visibility, possibility of future partnerships with Roche and awards for the winning startup. Through this challenge, Roche aims to find a better outcome for the patient, with solutions that allow the correct diagnosis within the shortest time possible, as well as the targeting of the most appropriate treatment for his case, thus contributing to the sustainability of the patient. health system.
Our focus is to find solutions that seek greater centralization of information; support the clinical staff in making the medical decision; ensure the adequate use of the resources involved in health, and enable quality medical education, with constant updating of the professionals involved.
We are looking for partner startups who share our vision and who are working in this search for personalized medicine solutions
(All conditions for awards must be consulted in the Regulation)
Solutions we are looking for
The challenge “Realizing Precision Medicine” proposes that entrepreneurs submit projects / solutions of promising technologies / products / services that provide greater centralization of information linked to diagnostics; support the clinical staff in making the medical decision; guarantee the adequate use of resources involved in health, and the possibility of quality medical education, with constant updating of the professionals involved.
This topic is of great relevance for the search for a better outcome to the patient,
with solutions that provide the correct diagnosis within the shortest time possible, as well as the direction to the treatment most appropriate for their case, thus contributing to the sustainability of the Brazilian health system.
Trackable / cloud data
Apps, software, artificial intelligence
New tests and diagnostics as well as imprecise and non-evidence-based solutions will not be valid.KNOW MORE
What is being awarded and to how many startups?
a) Participation in a 01 (one) week immersion program for 02 (two) entrepreneurs from the winning startup in the Digital Health Accelerator (Werk1, Grafinger Straße 6, München, Germany) at Roche Diagnóstica. The program will include networking with digital health startups, Roche specialists / local investors; deep-dive week with business coaching; ExpoDay with Roche / other companies and possibility to use the co-working space.
b) Subsidy of consulting services to assist in the definition of business model, growth strategy or internal structuring of the same.
Roche reserves the right to review and approve any finalists and may elect to refuse and / or revoke any prize at any time, acting in its sole discretion.
(All conditions for awards must be consulted in the Regulation).
Is it ok if some of the information I submit is confidential?
Will there be investment in the winning startup?
What happens with Intellectual Property?
Is the challenge opened only to Brazilians?
What stage are startups eligible to apply?
- Beta: startup has a structured technology / product / service and has validation tests performed which may include (but are not limited to) prototype construction, pilot testing, Minimum Viable Product (MVP);
- Launched: startup has already completed the testing and validation phase and has introduced the technology/product/service in the market, can have users / relevant volume of patient data and / or have regulatory approval completed.
Startups wishing to be eligible for prizes need to be formally incorporated in the tax authorities of their country of origin until the completion of stage II of the challenge assessment (even if this is not the case at the time of their initial registration via the platform).
Is this a long term program?
When is the application deadline?
How is the application process like?
Step 2 - EVALUATION - In this stage, the projects / solutions submitted by the startups are evaluated by the Roche body of evaluators and potentially other partners (to be designated by Roche), with the objective of identifying the projects / solutions with greater adherence to the objectives of challenge, according to the criteria in the subitems below.
Please check the Rules to understand exactly how the evaluation process will take place.
When and where will the winner be announced?
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is one of the world’s largest biotech companies, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics. Roche’s personalized healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Roche was one of the first companies to recognize the importance of external innovation. Roche Partnering was created more than 10 years ago with the aim of becoming the partner of choice for biotechnology companies and research institutes worldwide. Since then, we have maintained a model that values external innovation as highly as our own internally derived discoveries and established collaborations as the cornerstone of our R&D strategy. Through partnerships we can build a better future together with medicines and technologies that make a real difference to patients.
For more information please visit www.roche.com.br